IAS Symposium 2024
Meeting category
Date(s)
22 Jul 2024
Location
Munich, Germany

Leveraging Innovations to End the HIV Pandemic | Satellite Symposium at AIDS 2024

General
What's New?
  • We are happy to announce that "Leveraging Innovations to End the HIV Pandemic" symposium at AIDS 2024 will be held as a hybrid symposium on Monday 22 July 22 2024, from 15:00 - 16:30 CEST. The symposium will be in Hall B0b/Channel 5.

  • AIDS 2024, the 25th Internation AIDS Conference will take place at Messe München: the Trade Fair Center Messe München and the ICM – International Congress Center Messe München, in Munich, Germany.
     

  • The registration for this symposium will be handled by the organizers of AIDS 2024. Click here for more information.
     

  • To stay updated on the relevant developments, make sure you are signed up for our newsletter

About this Program

Over the past decades, the landscape of HIV medicine has evolved dramatically, ushering in transformative advancements across diagnosis, treatment, and prevention.

Injectable ART has revolutionized treatment and prevention options, offering patients and providers newfound flexibility and efficacy. However, to fully harness the potential of these innovations, continuous education and training for healthcare providers is essential. Equally crucial is empowering patients with comprehensive understanding through innovative approaches to education.

Our symposium, "Leveraging Innovations to End the HIV Pandemic," serves as a beacon for healthcare providers seeking to stay at the cutting edge of HIV care. Through engaging discussions and comprehensive insights, participants will gain a deep understanding of the latest breakthroughs and learn how to seamlessly integrate them into clinical practice.

By fostering collaboration and embracing patient-centered strategies, we aim to propel the field forward, reducing transmission rates and enhancing the quality of life for individuals living with HIV.

Program Chair

General Information 

Who Should Attend?
Clinicians and allied healthcare professionals caring for PLWHIV, as well as clinical virologists, researchers, immunologists, policymakers, NGO representatives, community advocates, and all other relevant stakeholders.
Learning Objectives
After participating in this activity, participants will be able to:

- Identify how innovations in ARV therapy have shaped HIV care in the past and identify how to continue to integrate innovations into the future of clinical practice.
- Describe current data regarding the use of long-acting ARV for HIV prevention and treatment.
- Gain a better understanding of how to utilize long-acting ARV to improve HIV prevention and treatment.
- Learn from successful examples of innovation implementation in HIV care.
- Highlight a holistic view of embracing innovation in all aspects of HIV prevention and care, considering the spectrum of challenges faced by clinicians and the community.

Practical Information 

Accommodation
Accommodation is not included in the registration fee.
Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Language
The official language of the conference/meeting/workshop is English
Translation will/will not be provided.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration

Registration is now open!

The Leveraging Innovations to End the HIV Pandemic Symposium is part of AIDS 2024. You can register for the symposium through the AIDS 2024 website. Registration fees including the payment and procedure of the online registration can be found on their website.

From Virology Education, there are no additional fees required to attend the symposium.

Program
Preliminary Program

The program of Leveraging Innovations to End the HIV Pandemic is currently under development and subject to changes. The below times are set in Central European Summer Time (CEST). Please, use this tool to convert the timing into your time zone. 

Monday, 22 July 

Session 1: Current Tools - 15:00
15:00
Opening & Welcome
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
15:02
30 Years of Innovations: Their Role in the Current Success of ARV Therapy
Sharon Lewin, AO, FRACP, PhD, FAHMS
Peter Doherty Institute for Infection and Immunity, Australia
15:10
Long Acting PrEP- Clinical Trials and Real World Data
Jürgen Rockstroh, MD
University of Bonn, Germany
15:25
Long Acting ARV Therapy- Clinical Trials and Real World Data
Chloe Orkin, MBChB, FRCP, MD
Queen Mary University of London, United Kingdom
15:40
Meeting the Challenge: Long Acting ARV in Difficult to Treat PLWHIV
Monica Gandhi, MD, MPH
University of California San Francisco, United States
15:52
Audience Q&A
16:04
Round Table Discussion: Innovations in HIV Care- Looking to the Future
François Venter, MD, FCP, PhD
Ezintsha, University of the Witwatersrand, South Africa
Monica Gandhi, MD, MPH
University of California San Francisco, United States
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
Ndivhuwo Rambau
Ritshidze, South Africa
16:29
Closing Remarks / Key Messages
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
Committees
Program Chair
Support

The Leveraging Innovations to End the HIV Pandemic symposium is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or the selection of faculty for this educational activity.

Accreditation
Accreditation Statement
EACCME logo

The Leveraging Innovations to End the HIV Pandemic, Munich, Germany, Germany 22/07/2024 - 22/07/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.


Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College
of Physicians and Surgeons of Canada.

Language